Parcion Private Wealth LLC raised its position in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 56.2% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,690 shares of the financial services provider's stock after acquiring an additional 1,688 shares during the quarter. Parcion Private Wealth LLC's holdings in CME Group were worth $1,244,000 as of its most recent SEC filing.
A number of other institutional investors have also bought and sold shares of the company. Wayfinding Financial LLC acquired a new position in shares of CME Group during the first quarter valued at about $25,000. Cornerstone Planning Group LLC raised its holdings in shares of CME Group by 122.2% in the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock worth $26,000 after acquiring an additional 55 shares during the last quarter. New Age Alpha Advisors LLC raised its holdings in shares of CME Group by 50.0% in the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after acquiring an additional 43 shares during the last quarter. Golden State Wealth Management LLC raised its holdings in shares of CME Group by 612.5% in the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock worth $30,000 after acquiring an additional 98 shares during the last quarter. Finally, Alpine Bank Wealth Management acquired a new stake in shares of CME Group in the 1st quarter worth about $32,000. Institutional investors own 87.75% of the company's stock.
CME Group Stock Performance
Shares of CME Group stock traded down $3.12 on Friday, reaching $274.70. 2,197,249 shares of the company traded hands, compared to its average volume of 2,181,258. CME Group Inc. has a 52 week low of $193.25 and a 52 week high of $290.79. The company has a 50 day moving average of $275.89 and a 200 day moving average of $260.65. The firm has a market capitalization of $98.99 billion, a PE ratio of 27.64, a PEG ratio of 4.86 and a beta of 0.44. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02.
CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, topping the consensus estimate of $2.61 by $0.19. The company had revenue of $1.64 billion during the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a net margin of 57.71% and a return on equity of 14.03%. CME Group's revenue for the quarter was up 10.4% on a year-over-year basis. During the same period last year, the firm earned $2.50 EPS. Equities analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current year.
CME Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, June 25th. Investors of record on Monday, June 9th were issued a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.82%. The ex-dividend date of this dividend was Monday, June 9th. CME Group's dividend payout ratio (DPR) is presently 50.30%.
Insider Buying and Selling
In related news, Director Phyllis M. Lockett sold 1,060 shares of the firm's stock in a transaction that occurred on Monday, May 19th. The shares were sold at an average price of $277.88, for a total value of $294,552.80. Following the completion of the transaction, the director directly owned 3,108 shares of the company's stock, valued at approximately $863,651.04. This trade represents a 25.43% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Dennis Suskind sold 1,000 shares of the firm's stock in a transaction on Tuesday, April 29th. The shares were sold at an average price of $271.28, for a total transaction of $271,280.00. Following the completion of the transaction, the director directly owned 2,915 shares of the company's stock, valued at approximately $790,781.20. The trade was a 25.54% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 13,400 shares of company stock worth $3,680,610 in the last 90 days. 0.30% of the stock is currently owned by company insiders.
Analysts Set New Price Targets
A number of equities research analysts recently weighed in on the stock. Wall Street Zen lowered shares of CME Group from a "hold" rating to a "sell" rating in a report on Sunday, July 13th. Keefe, Bruyette & Woods upped their target price on shares of CME Group from $265.00 to $273.00 and gave the stock a "market perform" rating in a report on Thursday, April 24th. JPMorgan Chase & Co. lowered their target price on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating on the stock in a report on Thursday, April 24th. Bank of America increased their price objective on shares of CME Group from $200.00 to $219.00 and gave the company an "underperform" rating in a research note on Wednesday, April 2nd. Finally, Piper Sandler increased their price objective on shares of CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a research note on Tuesday. Four equities research analysts have rated the stock with a sell rating, eight have given a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $261.80.
Get Our Latest Report on CME
CME Group Profile
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Stories

Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.